Your browser doesn't support javascript.
loading
Evaluation Value of Invasion Area PET-CT Scanning for Chemotherapeutic Efficacy and Prognosis of Patients with Lymphoma / 中国实验血液学杂志
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-272495
Biblioteca responsável: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the evaluation value of invasion area PET-CT scanning for chemotherapeutic efficacy and prognosis of patients with lymphoma.</p><p><b>METHODS</b>A total of 98 newly diagnosed patients with lymphoma received the chemotherapy by R-CHOP protocol, the PET-CT scan of whole body and invasion area was performed after 6 cycle of chemotherapy. The invasion area was determined by PET-CT scan results before chemotherapy. The difference of clinical stage, clinical efficacy, radiation dose and scanning time were compared between PET-CT scanning of whole body and invasion area.</p><p><b>RESULTS</b>The clinical stages of PET-CT scaning of whole body and invasion area were complete consistent, the consisitent rate of clinical stages from whole body and invasion area PET-CT scaning with Ann Arbor staging was 95.9%(94/98). Whole body PET-CT scan showed that 68 cases achieved CR, 26 cases achieved PR, 1 case achieved SD, 3 cases achieved PD. PET-CT scan of invasion area showed that 68 cases achieved CR, 24 cases achieved PR, 2 cases achieved SD, and 4 cases achieved PD; the PET-CT scan results of the whole body and the invasion area was consistent with CR. In 68 patients with CR, the radiation dose of CT, PET and PET-CT was significantly lower than that of whole body PET-CT, and the scanning time was significantly less than that of whole body PET-CT (P < 0.05).</p><p><b>CONCLUSION</b>For clinical efficicacy with CR patients, the scan results of whole body and invasion area PET-CT are consistent, and the PET-CT invasion area can significantly reduce the radiation dose and scanning time; and for PR, SD and PD patients, the whole body PET-CT scan should be performed to evaluation clinical efficiency.</p>
Assuntos
Texto completo: Disponível Contexto em Saúde: ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis Problema de saúde: Linfomas e Mieloma Múltiplo Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Prognóstico / Vincristina / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Tomografia Computadorizada por Raios X / Ciclofosfamida / Usos Terapêuticos / Tomografia por Emissão de Pósitrons / Diagnóstico Tipo de estudo: Estudo diagnóstico / Guia de prática clínica / Estudo prognóstico Limite: Humanos Idioma: Chinês Revista: Journal of Experimental Hematology Ano de publicação: 2016 Tipo de documento: Artigo
Texto completo: Disponível Contexto em Saúde: ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis Problema de saúde: Linfomas e Mieloma Múltiplo Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Prognóstico / Vincristina / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Tomografia Computadorizada por Raios X / Ciclofosfamida / Usos Terapêuticos / Tomografia por Emissão de Pósitrons / Diagnóstico Tipo de estudo: Estudo diagnóstico / Guia de prática clínica / Estudo prognóstico Limite: Humanos Idioma: Chinês Revista: Journal of Experimental Hematology Ano de publicação: 2016 Tipo de documento: Artigo
...